Tolleson Wealth Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-33,250
| Closed | -$3.39M | – | 82 |
|
|
2023
Q2 | $3.39M | Sell |
33,250
-7,000
| -17% | -$714K | 0.82% | 16 |
|
|
2023
Q1 | $3.66M | Sell |
40,250
-7,000
| -15% | -$637K | 0.95% | 19 |
|
|
2022
Q4 | $1.8M | Hold |
47,250
| – | – | 0.49% | 25 |
|
|
2022
Q3 | $1.19M | Hold |
47,250
| – | – | 0.36% | 35 |
|
|
2022
Q2 | $1.44M | Hold |
47,250
| – | – | 0.41% | 31 |
|
|
2022
Q1 | $1.55M | Hold |
47,250
| – | – | 0.46% | 32 |
|
|
2021
Q4 | $1.25M | Sell |
47,250
-13,500
| -22% | -$356K | 0.34% | 38 |
|
|
2021
Q3 | $6.11M | Sell |
60,750
-20,250
| -25% | -$2.04M | 1.73% | 13 |
|
|
2021
Q2 | $11.5M | Sell |
81,000
-27,000
| -25% | -$3.82M | 3.09% | 8 |
|
|
2021
Q1 | $10.8M | Buy |
+108,000
| New | +$10.8M | 3.25% | 9 |
|